Columbus McKinnon Corp (CMCO) stock
Close on Nov 17, 2026Market cap $572.96MP/E –Yield 1.41%
Earnings
Columbus McKinnon's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Columbus McKinnon's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Dec 31, 2026 | Feb 8, 2027Expected | – | – | – | – | – |
| Q2 FY2027ended Sep 30, 2026 | Nov 3, 2026before the open | $539.30M | – | -$0.76 | $0.61 | Release |
| Q1 FY2027ended Jun 30, 2026 | Jul 30, 2026before the open | $531.50M | +125.3% | -$2.05 | $0.61 | Release |
| Q4 FY2026ended Mar 31, 2026 | Jun 4, 2026before the open | $437.80M | +77.3% | -$5.78 | $0.24 | Release |
| Q3 FY2026ended Dec 31, 2025 | Feb 9, 2026after the close | $258.70M | +10.5% | $0.21 | $0.62 | Release |
| Q2 FY2026ended Sep 30, 2025 | Oct 30, 2025before the open | – | – | – | – | Release |
| Q1 FY2026ended Jun 30, 2025 | Jul 30, 2025before the open | $235.90M | -1.6% | -$0.07 | $0.50 | Release |
| Q4 FY2025ended Mar 31, 2025 | May 28, 2025before the open | $246.90M | -7.0% | -$0.09 | $0.60 | Release |
| Q3 FY2025ended Dec 31, 2024 | Feb 10, 2025after the close | $234.10M | -7.9% | $0.14 | $0.56 | Release |
| Q2 FY2025ended Sep 30, 2024 | Oct 30, 2024before the open | $242.30M | -6.2% | -$0.52 | $0.70 | Release |
| Q1 FY2025ended Jun 30, 2024 | Jul 31, 2024before the open | $239.70M | +1.8% | $0.30 | $0.62 | Release |
| Q4 FY2024ended Mar 31, 2024 | May 29, 2024before the open | $265.50M | +4.6% | $0.41 | $0.75 | Release |
| Q3 FY2024ended Dec 31, 2023 | Jan 31, 2024before the open | $254.10M | +10.3% | $0.34 | $0.74 | Release |
| Q2 FY2024ended Sep 30, 2023 | Nov 1, 2023before the open | $258.40M | +11.4% | $0.55 | $0.76 | Release |
| Q1 FY2024ended Jun 30, 2023 | Aug 2, 2023before the open | $235.50M | +7.0% | $0.32 | $0.62 | Release |
| Q4 FY2023ended Mar 31, 2023 | May 25, 2023after the close | $253.80M | +0.2% | $0.48 | $0.80 | Release |
| Q3 FY2023ended Dec 31, 2022 | Feb 1, 2023after the close | $230.40M | +6.6% | $0.42 | $0.72 | Release |
| Q2 FY2023ended Sep 30, 2022 | Oct 27, 2022before the open | $232.00M | +3.8% | $0.49 | $0.73 | Release |
| Q1 FY2023ended Jun 30, 2022 | Jul 28, 2022after the close | $220.00M | – | $0.29 | $0.69 | Release |
| Q4 FY2022ended Mar 31, 2022 | May 25, 2022after the close | $253.40M | – | $0.41 | $0.79 | Release |
| Q3 FY2022ended Dec 31, 2021 | Jan 27, 2022after the close | $216.10M | – | $0.34 | $0.60 | Release |
| Q2 FY2022ended Sep 30, 2021 | Oct 28, 2021after the close | $223.60M | – | $0.53 | $0.74 | Release |
| Q1 FY2022ended Jun 30, 2021 | Jul 29, 2021after the close | – | – | – | – | Filing |
| Q4 FY2021ended Mar 31, 2021 | Apr 28, 2021after the close | – | – | – | – | Filing |
| Q3 FY2021ended Dec 31, 2020 | Jan 28, 2021after the close | – | – | – | – | Filing |
| Q2 FY2021ended Sep 30, 2020 | Oct 29, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Columbus McKinnon's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net salesGAAP | FY2027 | $2.13B – $2.17B | – | New | Nov 3, 2026 |
| Net sales | FY2027 | $2.09B – $2.15B | – | New | Jul 30, 2026 |
| revenue | FY2027 | $1.50B | $1.50B | Reaffirmed | May 25, 2023 |
| Adjusted EBITDAnon-GAAP | FY2027 | $405.00M – $420.00M | – | New | Jul 30, 2026 |
| Adjusted EBITDA 5non-GAAP | FY2027 | $425.00M – $440.00M | – | New | Nov 3, 2026 |
| adjusted EBITDA marginnon-GAAP | FY2027 | 21% | 21% | Reaffirmed | May 25, 2023 |
| Adjusted EPSnon-GAAP | FY2027 | $1.90 – $2.10 | – | New | Jul 30, 2026 |
| Adjusted EPS 5non-GAAP | FY2027 | $2.00 – $2.15 | – | New | Nov 3, 2026 |
| Capital expenditures | FY2027 | $45.00M – $55.00M | – | New | Nov 3, 2026 |
| Adjusted Diluted Shares Outstandingnon-GAAP | FY2027 | 52 | 52 | Reaffirmed | Jul 30, 2026 |
| Adjusted Diluted Shares Outstanding 5non-GAAP | FY2027 | 52 | – | New | Nov 3, 2026 |
| amortization expense | FY2027 | $135.00M – $140.00M | $135.00M – $140.00M | Lowered | Jul 30, 2026 |
| Amortization expense | FY2027 | $130.00M – $135.00M | – | Lowered | Nov 3, 2026 |
| depreciation expense | FY2027 | $75.00M – $80.00M | $75.00M – $80.00M | Lowered | Jul 30, 2026 |
| Depreciation expense | FY2027 | $80.00M – $85.00M | – | Lowered | Nov 3, 2026 |
| effective tax rate | FY2027 | 25% | – | New | Jun 4, 2026 |
| interest expense | FY2027 | $185.00M – $190.00M | $185.00M – $190.00M | Raised | Jul 30, 2026 |
| Interest expense | FY2027 | $185.00M – $190.00M | – | New | Nov 3, 2026 |
| Normalized effective tax rate | FY2027 | 25% | – | Reaffirmed | Jul 30, 2026 |
| Normalized effective tax rate as used in the calculation of Adjusted EPSnon-GAAP | FY2027 | 25% | – | New | Nov 3, 2026 |
Guidance vs results
The last range Columbus McKinnon gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q4 FY2024 | Revenue | $260.00M – $270.00M | $265.50M | Within range |
| Q3 FY2024 | Revenue | $245.00M – $255.00M | $254.10M | Within range |
| Q2 FY2024 | Revenue | $250.00M – $260.00M | $258.40M | Within range |
| Q1 FY2024 | Revenue | $235.00M – $240.00M | $235.50M | Within range |
| Q4 FY2023 | Revenue | $240.00M – $250.00M | $253.80M | Above range |
| Q3 FY2023 | Revenue | $225.00M – $235.00M | $230.40M | Within range |
| Q2 FY2023 | Revenue | $230.00M – $240.00M | $232.00M | Within range |
| Q1 FY2023 | Revenue | $220.00M – $230.00M | $220.00M | Within range |
| Q4 FY2022 | Revenue | $235.00M | $253.40M | Above range |
| Q3 FY2022 | Revenue | $215.00M | $216.10M | Above range |
Guidance history
Every forecast Columbus McKinnon put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 3, 2026 | Capital expenditures | FY2027 | $45.00M – $55.00M | New |
| Nov 3, 2026 | Adjusted EBITDA 5 | FY2027 | $425.00M – $440.00M | New |
| Nov 3, 2026 | Adjusted EPS 5 | FY2027 | $2.00 – $2.15 | New |
| Nov 3, 2026 | Adjusted Diluted Shares Outstanding 5 | FY2027 | 52 | New |
| Nov 3, 2026 | Normalized effective tax rate as used in the calculation of Adjusted EPS | FY2027 | 25% | New |
| Nov 3, 2026 | Interest expense | FY2027 | $185.00M – $190.00M | New |
| Nov 3, 2026 | Amortization expense | FY2027 | $130.00M – $135.00M | Lowered |
| Nov 3, 2026 | Depreciation expense | FY2027 | $80.00M – $85.00M | Lowered |
| Nov 3, 2026 | Net sales | FY2027 | $2.13B – $2.17B | New |
| Jul 30, 2026 | Adjusted EBITDA | FY2027 | $405.00M – $420.00M | New |
| Jul 30, 2026 | Adjusted EPS | FY2027 | $1.90 – $2.10 | New |
| Jul 30, 2026 | Adjusted Diluted Shares Outstanding | FY2027 | 52 | Reaffirmed |
| Jul 30, 2026 | Normalized effective tax rate | FY2027 | 25% | Reaffirmed |
| Jul 30, 2026 | interest expense | FY2027 | $185.00M – $190.00M | Raised |
| Jul 30, 2026 | amortization expense | FY2027 | $135.00M – $140.00M | Lowered |
| Jul 30, 2026 | depreciation expense | FY2027 | $75.00M – $80.00M | Lowered |
| Jul 30, 2026 | Net sales | FY2027 | $2.09B – $2.15B | New |
| Jun 4, 2026 | Adjusted Diluted Shares Outstanding | FY2027 | 52 | New |
| Jun 4, 2026 | effective tax rate | FY2027 | 25% | New |
| Jun 4, 2026 | interest expense | FY2027 | $185.00M – $190.00M | New |
| Jun 4, 2026 | amortization expense | FY2027 | $135.00M – $140.00M | Lowered |
| Jun 4, 2026 | depreciation expense | FY2027 | $75.00M – $80.00M | Lowered |
| Oct 30, 2025 | diluted average shares outstanding | FY2026 | 29 | New |
| Oct 30, 2025 | effective tax rate | FY2026 | 25% | New |
| Oct 30, 2025 | tariff-related impact | FY2026 | $10.00M | New |
| Oct 30, 2025 | interest expense | FY2026 | $35.00M | Raised |
| Oct 30, 2025 | amortization | FY2026 | $30.00M | Lowered |
| Feb 10, 2025 | Capital Expenditures | FY2025 | $18.00M – $22.00M | New |
| Feb 10, 2025 | Net Leverage Ratio | FY2025 | 3 | New |
| Oct 30, 2024 | Capital Expenditures | FY2025 | $20.00M – $25.00M | Lowered |
| Oct 30, 2024 | Net Leverage Ratio | FY2025 | 2.3 | Raised |
| Jul 31, 2024 | Capital Expenditures | FY2025 | $20.00M – $30.00M | Reaffirmed |
| Jul 31, 2024 | Net Leverage Ratio | FY2025 | 2 | Reaffirmed |
| May 29, 2024 | Capital Expenditures | FY2025 | $20.00M – $30.00M | New |
| May 29, 2024 | Net Leverage Ratio | FY2025 | 2 | New |
| Jan 31, 2024 | net sales | Q4 FY2024 | $260.00M – $270.00M | New |
| Nov 1, 2023 | sales | Q3 FY2024 | $245.00M – $255.00M | New |
| Aug 2, 2023 | sales | Q2 FY2024 | $250.00M – $260.00M | New |
| May 25, 2023 | adjusted EBITDA margin | FY2027 | 21% | Reaffirmed |
| May 25, 2023 | sales | Q1 FY2024 | $235.00M – $240.00M | New |
| May 25, 2023 | revenue | FY2027 | $1.50B | Reaffirmed |
| Feb 1, 2023 | sales | Q4 FY2023 | $240.00M – $250.00M | New |
| Feb 1, 2023 | growth rate | FY2023 | +6% | New |
| Oct 27, 2022 | sales | Q3 FY2023 | $225.00M – $235.00M | New |
| Jul 28, 2022 | adjusted EBITDA margin | FY2027 | 21% | New |
| Jul 28, 2022 | sales | Q2 FY2023 | $230.00M – $240.00M | New |
| Jul 28, 2022 | revenue | FY2027 | $1.50B | New |
| May 25, 2022 | sales | Q1 FY2023 | $220.00M – $230.00M | New |
| Jan 27, 2022 | sales | Q4 FY2022 | $235.00M | New |
| Oct 28, 2021 | sales | Q3 FY2022 | $215.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Columbus McKinnon filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- Update
- Results
- Results
- News
- Update
- Update
- News
- Results
- Results
- News
- Update
- Results
See a number that looks wrong?